Phospholipase D2 Antikörper (Middle Region)
-
- Target Alle Phospholipase D2 (PLD2) Antikörper anzeigen
- Phospholipase D2 (PLD2)
-
Bindungsspezifität
- Middle Region
-
Reaktivität
- Human, Ratte, Rind (Kuh)
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Phospholipase D2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Kreuzreaktivität
- Ratte (Rattus), Rind (Kuh)
- Aufreinigung
- Purified
- Immunogen
- PLD2 antibody was raised in rabbit using the middle region of PLD2 as the immunogen
- Top Product
- Discover our top product PLD2 Primärantikörper
-
anti-Phospholipase D2 (PLD2) (AA 834-933) antibody
PLD2 Reaktivität: Human ELISA, IHC, FACS, ICC Wirt: Maus Monoclonal 7E4D9 unconjugated
anti-Phospholipase D2 (PLD2) (AA 834-933) antibodyPLD2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 1C5 unconjugated
anti-Phospholipase D2 (PLD2) (pTyr169) antibodyPLD2 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Phospholipase D2 (PLD2) (AA 1-165) antibodyPLD2 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Phospholipase D2 (PLD2) (AA 834-933) antibodyPLD2 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Phospholipase D2 (PLD2) (AA 1-180) antibodyPLD2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Phospholipase D2 (PLD2) (N-Term) antibodyPLD2 Reaktivität: Human, Ratte, Maus, Rind (Kuh), Pferd, Hund, Kaninchen, Meerschweinchen WB Wirt: Kaninchen Polyclonal unconjugated
anti-Phospholipase D2 (PLD2) (AA 467-516) antibodyPLD2 Reaktivität: Human, Ratte, Rind (Kuh), Affe WB Wirt: Kaninchen Polyclonal unconjugated
anti-Phospholipase D2 (PLD2) (N-Term) antibodyPLD2 Reaktivität: Human, Maus, Rind (Kuh) WB Wirt: Kaninchen Polyclonal unconjugated
anti-Phospholipase D2 (PLD2) (AA 136-185), (pTyr169) antibodyPLD2 Reaktivität: Human, Ratte, Maus WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
PLD2 Blocking Peptide, catalog no. 33R-2047, is also available for use as a blocking control in assays to test for specificity of this PLD2 antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Konzentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Target
- Phospholipase D2 (PLD2)
- Andere Bezeichnung
- PLD2 (PLD2 Produkte)
- Synonyme
- Pldc antikoerper, PLD2 antikoerper, phospholipase D2 antikoerper, PLD2 antikoerper, Pld2 antikoerper, pld2 antikoerper, CpipJ_CPIJ013122 antikoerper, VDBG_00892 antikoerper
- Hintergrund
- Phosphatidylcholine (PC)-specific phospholipases D (PLDs, EC 3.1.4.4) catalyze the hydrolysis of PC to produce phosphatidic acid and choline. Activation of PC-specific PLDs occurs as a consequence of agonist stimulation of both tyrosine kinase and G protein-coupled receptors. PC-specific PLDs have been proposed to function in regulated secretion, cytoskeletal reorganization, transcriptional regulation, and cell cycle control. Synonyms: Polyclonal PLD2 antibody, Anti-PLD2 antibody, phospholipase D2 antibody.
- Pathways
- RTK Signalweg, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Regulation of G-Protein Coupled Receptor Protein Signaling
-
